Liver Diseases  >>  Defitelio (defibrotide)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Defitelio (defibrotide) / IRCCS San Raffaele Hospital, Jazz
NCT00358501: Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients

Completed
3
134
US, Canada
Defibrotide
Jazz Pharmaceuticals, FDA Office of Orphan Products Development
Severe Hepatic Veno-Occlusive Disease
09/08
03/15

Download Options